http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#Head http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#assertion http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#provenance http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#pubinfo http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#assertion http://purl.obolibrary.org/obo/DOID_1781 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_1781 http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00279 http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#association http://www.w3.org/2000/01/rdf-schema#label liothyronine sodium is an l triiodothyronine t3 indicated for hypothyroidism as replacement in primary thyroidal secondary pituitary and tertiary hypothalamic congenital or acquired hypothyroidism 1 1 pituitary thyroid stimulating hormone tsh suppression as an adjunct to surgery and radioiodine therapy in the management of well differentiated thyroid cancer 1 2 thyroid suppression test as a diagnostic agent in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy 1 3 limitations of use not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine sufficient patients 1 not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis 1 liothyronine sodium is indicated as a replacement therapy in primary thyroidal secondary pituitary and tertiary hypothalamic congenital or acquired hypothyroidism liothyronine sodium is indicated as an adjunct to surgery and radioiodine therapy in the management of well differentiated thyroid cancer liothyronine sodium is indicated as a diagnostic agent in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy limitations of use liothyronine sodium is not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine sufficient patients as there are no clinical benefits and overtreatment with liothyronine sodium may induce hyperthyroidism see warnings and precautions 5 4 liothyronine sodium is not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00279 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#provenance http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#pubinfo http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#sig http://purl.org/nanopub/x/hasSignature cZvtVgtQxt+5NuWZ9OnxWLvUSz9MNHnTIJGr3+uxJfn+tytbs8cwhWvSsWqnnIpfFU4REcL4NndUpLCsh4fY1HnI8sjQM4FfS/NItIoWMIws+EIgD7PPPa0kGhxKeVs23MItnZxJYtLIkrNKtzkSnk+qzgb7RoVol+yh/BLGVPE= http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY http://purl.org/dc/terms/created 2021-06-12T15:43:40.917+02:00 http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAUhiElz_5AUQ38pce4vVoogc25rioBmrDvF8CFYZrDoY https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs